Management of COVID-19 disease in adults
Abstract
Empirical treatment should be planned for patients admitted to the hospital with an initial diagnosis of COVID-19, pneumonia and severe pneumonia, taking into account bacterial and viral infections. The choice of antibiotic to be used in empirical treatment is based on the patient's clinical condition (nosocomial pneumonia, nosocomial pneumonia, sepsis, co-morbidities, immunosuppression, medical treatment in the last 3 months, previous antibiotic use), local epidemiological data and treatment guidelines.
References
CDC, 2020.
ÜST, 2020
Türkiyə Respublikasının Sağlıq Bakanlığı, 2020.
Mehta P, et al. Lancet doi.org/10.1016/ S0140-6736(20)30628-0
Debaugnies F, Mahadeb B, Ferster A, et al. Performances of the H-Score for Diagnosis of Hemophagocytic Lymphohistiocytosis in Adult and Pediatric Patients. Am J Clin Pathol. 2016;145(6):862–870. doi:10.1093/ajcp/aqw076
Fardet L, Galicier L, Lambotte O, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014;66(9):2613–2620. doi:10.1002/art.38690
Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124-131
Keywords
virus
coronavirus
acute respiratory diseases COVID-19
вирус
коронавирус
острые респираторные заболевания COVID-19
virus
koronavirus
kəskin respirator xəstəliklər
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Most read articles by the same author(s)
- Shahla Ismayilova , Nabil Seyidov , Lala Rzayeva, Methodical aids for conducting screening programs in children , EURASIAN JOURNAL OF CLINICAL SCIENCES: Vol. 2 No. 2 (2020): Eurasian Journal of Clinical Sciences